CIDEC Antibody [Alexa Fluor® 532]

• Reactivity: Hu
• Applications: WB, ICC/IF
• Clonality: Polyclonal
• Host: Sheep
• Conjugate: Alexa Fluor 532

CIDEC Antibody [Alexa Fluor® 532] Summary

• Immunogen: E. coli-derived recombinant human CIDEC
  Met75-His176
  Accession # Q96AQ7
• Specificity: Detects human CIDEC in direct ELISAs and Western blots. In direct ELISAs, less than 3% cross-reactivity with recombinant human CIDEA is observed.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Sheep
• Purity Statement: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Immunocytochemistry
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for CIDEC Antibody [Alexa Fluor® 532]

• cell death activator CIDE-3
• cell death-inducing DFFA-like effector c
• Cell death-inducing DFFA-like effector protein C
• CIDE-3
• CIDEC
• CIDEX
• Fat-specific protein FSP27 homolog
• FLJ20871
• FSP27
• FSP27fat specific protein 27

Background

CIDE-3 (Cell death-Inducing DNA fragmentation factor-alpha -like Effector protein 3; also CIDEC and FSP27 in mouse) is a 24-32 kDa member of the CIDE family of molecules. It is a lipid droplet stabilizer that is expressed in hepatocytes and adipocytes, and found to be associated with both mitochondria and the surface of cytoplasmic lipid droplets. CIDE-3 is unstable in the absence of triglycerides and free fatty acids, and is subject to ubiquitin-mediated degradation. In the presence of elevated fatty acids or triglycerides, CIDE-3 half-life is prolonged, and it assists in the formation of lipid droplets. Although other CIDE family members are associated with the initiation of apoptosis, it is unclear if CIDE-3 possesses such activity. Human CIDE-3 is 238 amino acids (aa) in length, and contains one CIDE domain (aa 41-120). There are multiple isoform variants. Two possesses alternative start sites, one at Met74, and another 14 aa upstream of the standard site. A third isoform shows an insertion of ten aa after Lys69, while a fourth isoform possesses a 60 aa substitution for aa 70-238. Over aa 75-176, human CIDE-3 shares 84% aa identity with mouse CIDE-3.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.